View in EDS

TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.

Saved in:
Bibliographic Details
Title: TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.
Authors: Azar F; Transgene SA, Illkirch-Graffenstaden, France., Deforges J; Transgene SA, Illkirch-Graffenstaden, France., Demeusoit C; Transgene SA, Illkirch-Graffenstaden, France., Kleinpeter P; Transgene SA, Illkirch-Graffenstaden, France., Remy C; Transgene SA, Illkirch-Graffenstaden, France., Silvestre N; Transgene SA, Illkirch-Graffenstaden, France., Foloppe J; Transgene SA, Illkirch-Graffenstaden, France., Fend L; Transgene SA, Illkirch-Graffenstaden, France., Spring-Giusti C; Transgene SA, Illkirch-Graffenstaden, France., Quéméneur E; Transgene SA, Illkirch-Graffenstaden, France., Marchand JB; Transgene SA, Illkirch-Graffenstaden, France jem@transgene.fr.
Source: Journal for immunotherapy of cancer [J Immunother Cancer] 2024 Jul 25; Vol. 12 (7). Date of Electronic Publication: 2024 Jul 25.
Publication Type: Journal Article
Journal Info: Publisher: BMJ Publishing Group Ltd Country of Publication: England NLM ID: 101620585 Publication Model: Electronic Cited Medium: Internet ISSN: 2051-1426 (Electronic) Linking ISSN: 20511426 NLM ISO Abbreviation: J Immunother Cancer Subsets: MEDLINE
Database: MEDLINE Ultimate
FullText Text:
  Availability: 0
Header DbId: mdl
DbLabel: MEDLINE Ultimate
An: 39060022
AccessLevel: 2
PubType: Academic Journal
PubTypeId: academicJournal
PreciseRelevancyScore: 0
IllustrationInfo
Items – Name: Title
  Label: Title
  Group: Ti
  Data: TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.
– Name: Author
  Label: Authors
  Group: Au
  Data: <searchLink fieldCode="AU" term="%22Azar+F%22">Azar F</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Deforges+J%22">Deforges J</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Demeusoit+C%22">Demeusoit C</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Kleinpeter+P%22">Kleinpeter P</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Remy+C%22">Remy C</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Silvestre+N%22">Silvestre N</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Foloppe+J%22">Foloppe J</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Fend+L%22">Fend L</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Spring-Giusti+C%22">Spring-Giusti C</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Quéméneur+E%22">Quéméneur E</searchLink>; Transgene SA, Illkirch-Graffenstaden, France.<br /><searchLink fieldCode="AU" term="%22Marchand+JB%22">Marchand JB</searchLink>; Transgene SA, Illkirch-Graffenstaden, France jem@transgene.fr.
– Name: TitleSource
  Label: Source
  Group: Src
  Data: <searchLink fieldCode="JN" term="%22101620585%22">Journal for immunotherapy of cancer</searchLink> [J Immunother Cancer] 2024 Jul 25; Vol. 12 (7). <i>Date of Electronic Publication: </i>2024 Jul 25.
– Name: TypePub
  Label: Publication Type
  Group: TypPub
  Data: Journal Article
– Name: TitleSource
  Label: Journal Info
  Group: Src
  Data: <i>Publisher: </i><searchLink fieldCode="PB" term="%22BMJ+Publishing+Group+Ltd%22">BMJ Publishing Group Ltd </searchLink><i>Country of Publication: </i>England <i>NLM ID: </i>101620585 <i>Publication Model: </i>Electronic <i>Cited Medium: </i>Internet <i>ISSN: </i>2051-1426 (Electronic) <i>Linking ISSN: </i><searchLink fieldCode="IS" term="%2220511426%22">20511426 </searchLink><i>NLM ISO Abbreviation: </i>J Immunother Cancer <i>Subsets: </i>MEDLINE
PLink https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&db=mdl&AN=39060022
RecordInfo BibRecord:
  BibEntity:
    Identifiers:
      – Type: doi
        Value: 10.1136/jitc-2024-009302
    Languages:
      – Code: eng
        Text: English
    Titles:
      – TitleFull: TG6050, an oncolytic vaccinia virus encoding interleukin-12 and anti-CTLA-4 antibody, favors tumor regression via profound immune remodeling of the tumor microenvironment.
        Type: main
  BibRelationships:
    HasContributorRelationships:
      – PersonEntity:
          Name:
            NameFull: Azar F
      – PersonEntity:
          Name:
            NameFull: Deforges J
      – PersonEntity:
          Name:
            NameFull: Demeusoit C
      – PersonEntity:
          Name:
            NameFull: Kleinpeter P
      – PersonEntity:
          Name:
            NameFull: Remy C
      – PersonEntity:
          Name:
            NameFull: Silvestre N
      – PersonEntity:
          Name:
            NameFull: Foloppe J
      – PersonEntity:
          Name:
            NameFull: Fend L
      – PersonEntity:
          Name:
            NameFull: Spring-Giusti C
      – PersonEntity:
          Name:
            NameFull: Quéméneur E
      – PersonEntity:
          Name:
            NameFull: Marchand JB
    IsPartOfRelationships:
      – BibEntity:
          Dates:
            – D: 25
              M: 07
              Text: 2024 Jul 25
              Type: published
              Y: 2024
          Identifiers:
            – Type: issn-electronic
              Value: 2051-1426
          Numbering:
            – Type: volume
              Value: 12
            – Type: issue
              Value: 7
          Titles:
            – TitleFull: Journal for immunotherapy of cancer
              Type: main
ResultId 1